Latest Insider Transactions at Myriad Genetics Inc (MYGN)
This section provides a real-time view of insider transactions for Myriad Genetics Inc (MYGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MYRIAD GENETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MYRIAD GENETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2021
|
Kevin Richard Haas Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+19.07%
|
-
|
|
Feb 18
2021
|
Margaret Ancona SVP, Chief of Staff |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
|
Feb 18
2021
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,175
-3.51%
|
$324,075
$29.69 P/Share
|
|
Feb 16
2021
|
Jerry S Lanchbury Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
80,000
-12.7%
|
$2,320,000
$29.71 P/Share
|
|
Feb 16
2021
|
Jerry S Lanchbury Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+10.49%
|
$1,440,000
$18.0 P/Share
|
|
Jan 08
2021
|
Paul Parkinson EVP Strategy and Innovation |
SELL
Open market or private sale
|
Direct |
11,824
-13.35%
|
$295,600
$25.0 P/Share
|
|
Dec 04
2020
|
S. Louise Phanstiel Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,889
+16.12%
|
-
|
|
Dec 04
2020
|
Heinrich Dreismann Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,889
+18.35%
|
-
|
|
Dec 04
2020
|
Dennis Langer Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,889
+17.16%
|
-
|
|
Dec 04
2020
|
Lee Nisley Newcomer Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,889
+36.56%
|
-
|
|
Dec 04
2020
|
Daniel K Spiegelman Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,889
+30.36%
|
-
|
|
Dec 04
2020
|
Daniel Skovronsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,889
+27.96%
|
-
|
|
Dec 04
2020
|
Colleen F Reitan Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,889
+36.56%
|
-
|
|
Nov 11
2020
|
S. Louise Phanstiel Director |
BUY
Open market or private purchase
|
Direct |
15,000
+18.34%
|
$240,000
$16.62 P/Share
|
|
Oct 31
2020
|
Paul Parkinson EVP Strategy and Innovation |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,218
-2.44%
|
$26,616
$12.43 P/Share
|
|
Oct 08
2020
|
Richard Bryan Riggsbee Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,954
+12.37%
|
-
|
|
Oct 08
2020
|
Jerry S Lanchbury Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,196
+13.72%
|
-
|
|
Oct 08
2020
|
Mark Verratti Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,258
+18.07%
|
-
|
|
Oct 08
2020
|
Nicole Lambert Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,211
+29.39%
|
-
|
|
Oct 08
2020
|
Benjamin Jackson E.V.P., General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
29,784
+25.25%
|
-
|
|
Oct 08
2020
|
Paul Parkinson EVP Strategy and Innovation |
BUY
Grant, award, or other acquisition
|
Direct |
21,730
+19.31%
|
-
|
|
Oct 08
2020
|
Jayne B. Hart Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,853
+21.09%
|
-
|
|
Sep 30
2020
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,653
-2.38%
|
$86,489
$13.04 P/Share
|
|
Sep 30
2020
|
Jerry S Lanchbury Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,544
-2.6%
|
$72,072
$13.04 P/Share
|
|
Sep 30
2020
|
Alexander Ford Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,653
-3.79%
|
$86,489
$13.04 P/Share
|
|
Sep 30
2020
|
Mark Verratti Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
725
-0.65%
|
$9,425
$13.04 P/Share
|
|
Sep 30
2020
|
Nicole Lambert Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
591
-0.94%
|
$7,683
$13.04 P/Share
|
|
Sep 30
2020
|
Benjamin Jackson E.V.P., General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
416
-0.71%
|
$5,408
$13.04 P/Share
|
|
Sep 30
2020
|
Jayne B. Hart Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,218
-4.33%
|
$28,834
$13.04 P/Share
|